Top Institutions in Ophthalmology
Leading academic ophthalmology centers and research institutions conduct clinical trials and translational research on retinal diseases including DME, leveraging expertise in intravitreal drug delivery, anti-VEGF therapies, and novel pharmacologic agents such as TKIs. These institutions often collaborate with pharmaceutical companies to design and execute phase 2 and 3 clinical trials, analyze efficacy and safety data, and develop new treatment paradigms.
-
#100
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive experience in diabetic retinopathy and macular edema. Their faculty have pioneered intravitreal therapies and novel drug delivery systems, contributing significantly to the development of anti-VEGF and TKI treatments.
-
#92
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a strong focus on retinal diseases and clinical trials in diabetic macular edema. Their research includes evaluation of new pharmacologic agents and sustained-release drug delivery systems.
-
#88
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a robust retinal research program with a focus on diabetic eye diseases and innovative treatments. Their investigators have contributed to the understanding and clinical application of intravitreal therapies for DME.
-
#85
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its translational research in retinal diseases, including diabetic macular edema. Their work spans from molecular mechanisms to clinical trials of novel therapeutics such as TKIs and sustained-release implants.